首页> 美国卫生研究院文献>Aging (Albany NY) >circMET promotes NSCLC cell proliferation metastasis and immune evasion by regulating the miR-145-5p/CXCL3 axis
【2h】

circMET promotes NSCLC cell proliferation metastasis and immune evasion by regulating the miR-145-5p/CXCL3 axis

机译:通过调节miR-145-5p / cxcl3轴来促进NSCLC细胞增殖转移和免疫逃避

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In recent years, circular RNAs (circRNAs) have been increasingly reported to play a crucial role in the proliferation, migration, and invasion of non-small-cell lung cancer (NSCLC) cells. However, the circRNA MET (circMET) oncogenic mechanism that drives NSCLC development and progression remains largely unknown. In this study, the present results demonstrated that circMET expression was significantly higher in NSCLC tissues than in peritumoral tissues using quantitative real-time polymerase chain reaction. Notably, NSCLC patients with a large tumor diameter, poor differentiation and lymphatic metastasis had high RNA levels of circMET. Moreover, high circMET expression served as an independent risk factor for short overall survival (OS) and progression-free survival (PFS) in NSCLC patients. Next, we validated that circMET overexpression can enhance NSCLC cell proliferation, metastasis, and immune evasion in vitro. Mechanistically, our study uncovers that circMET acts as a miR-145-5p sponge to upregulate CXCL3 expression. Collectively, circMET regulates the miR-145-5p/CXCL3 axis and serves as a novel, promising diagnostic and prognostic biomarker in patients with NSCLC.
机译:近年来,循环RNA(Circrnas)越来越多地报道在非小细胞肺癌(NSCLC)细胞的增殖,迁移和侵袭中发挥至关重要的作用。然而,Circrna遇到(电路)致癌机制,驱动NSCLC发育和进展仍然很大程度上是未知的。在该研究中,本结果表明,使用定量实时聚合酶链反应的NSCLC组织中的NSCLC组织中的昼夜表达显着较高。值得注意的是,具有大肿瘤直径,分化差和淋巴结转移的NSCLC患者具有高RNA水平的电磁。此外,高循环表达作为NSCLC患者的短总存活(OS)和无进展生存(PFS)的独立危险因素。接下来,我们经过验证的那种过度表达可以增强NSCLC细胞增殖,转移和体外免疫逃逸。机械地,我们的研究揭示了Circomet作为miR-145-5p海绵,以上调CXCL3表达。集体,气体调节miR-145-5p / cxcl3轴,并用作NSCLC患者的新颖,有前途的诊断和预后生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号